✦ LIBER ✦

387 Vestibulotoxicity as a consequence of systemically administered tobramycin in Cystic Fibrosis patients

✍ Scribed by R.J. Scheenstra; E. Rijntjes; D.L. Tavy; H. Kingma; H.G. Heijerman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

386 Cochleotoxicity of systemically admi

✍ R.J. Scheenstra; H.G. Heijerman; D.J. Touw; E. Rijntjes 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

71 Pharmacokinetics of nasal administere

✍ Berkhout, M.C.; van Velzen, A.J.; Touw, D.J.; Bouazzaoui, L.H. el; Rijntjes, E.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Disposition of tobramycin in patients wi

✍ Jack Levy; Arnold L. Smith; Jeffrey R. Koup; Judy Williams-Warren; Bonnie Ramsey 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 691 KB

Long term effects of inhaled tobramycin

✍ I. Stelmach; A. Korzeniewska-Eksterowicz; T. Ruszczyk-Bilecka; M. Olszowiec-Chle 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Tobramycin-induced aquagenic wrinkling o

✍ M. W. Ludgate; D. Patel; S. Lamb 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

89 Evaluation of a twice daily tobramyci

✍ McCabe, D.; Rodgers, H.C. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 67 KB